Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

17.00
Delayed Data
As of May 18
 +0.10 / +0.59%
Today’s Change
11.90
Today|||52-Week Range
20.40
+11.84%
Year-to-Date
No recent news for Vanda Pharmaceuticals Inc.

Today’s Trading

Previous close16.90
Today’s open16.95
Day’s range16.75 - 17.10
Volume305,309
Average volume (3 months)682,118
Market cap$875.5M
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)+14.63%
Earnings growth (this year)+385.71%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+13.06%
P/E ratioNM
Price/Sales4.12
Price/Book5.75

Competitors

 Today’s
change
Today’s
% change
CYTKCytokinetics Inc0.000.00%
ACRSAclaris Therapeutics...+0.39+1.99%
FLXNFlexion Therapeutics...+1.12+4.20%
RVNCRevance Therapeutics...+0.05+0.16%
Data as of 4:00pm ET, 05/18/2018

Financials

Next reporting dateAugust 1, 2018
EPS forecast (this quarter)$0.04
Annual revenue (last year)$165.1M
Annual profit (last year)-$15.6M
Net profit margin-9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
Chief Financial Officer, Secretary &
Treasurer
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts